ALERTS: MERGERS - EUROPEAN UNION - HEALTHCARE - PHARMACEUTICAL INDUSTRY - INTERIM MEASURES - GUN JUMPING

Interim measures: The European Commission sends a statement of objections to two pharmaceutical companies informing them of the interim measures it intends to adopt (Grail / Illumina)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The European Commission and Illumina are at loggerheads over the proposed acquisition of Grail. The Commission is now threatening to put its money where its mouth is. Today, September 20, 2021, the Commission sent a Statement of Objections to Illumina and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Interim measures: The European Commission sends a statement of objections to two pharmaceutical companies informing them of the interim measures it intends to adopt (Grail / Illumina), 20 September 2021, Concurrences N° 4-2021, Art. N° 102514, www.concurrences.com

Visites 132

All reviews